Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267683
Status:
TERMINATED
Last Update Posted:
2023-11-02
First Post:
2005-12-20
Brief Title:
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2006-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-20
First Submit QC Date:
December 20 2005
Study First Post Date:
2005-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL